Drugs for irritable bowel syndrome.Med Lett Drugs Ther 2025 Feb 03; 67(1721):17-24.ML
Pub Type(s)
Journal Article
Language
eng
PubMed ID
39912839
Citation
"Drugs for Irritable Bowel Syndrome." The Medical Letter On Drugs and Therapeutics, vol. 67, no. 1721, 2025, pp. 17-24.
Drugs for irritable bowel syndrome. Med Lett Drugs Ther. 2025;67(1721):17-24.
(2025). Drugs for irritable bowel syndrome. The Medical Letter On Drugs and Therapeutics, 67(1721), 17-24. https://doi.org/10.58347/tml.2025.1721a
Drugs for Irritable Bowel Syndrome. Med Lett Drugs Ther. 2025 Feb 3;67(1721):17-24. PubMed PMID: 39912839.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Drugs for irritable bowel syndrome.
PY - 2025/2/6/medline
PY - 2025/2/6/pubmed
PY - 2025/2/6/entrez
KW - Amitiza
KW - Anaspaz
KW - Colestid
KW - IBgard
KW - Ibsrela
KW - Imodium
KW - Levbid
KW - Levsin
KW - Linzess
KW - Lotronex
KW - Miralax
KW - Norpramin
KW - Pamelor
KW - Pepogest
KW - Questran
KW - SSRIs
KW - Trulance
KW - Viberzi
KW - Welchol
KW - Xifaxan
KW - adverse effects
KW - alosetron
KW - amitriptyline
KW - cholestyramine
KW - cognitive behavioral therapy
KW - colesevelam
KW - colestipol
KW - constipation
KW - desipramine
KW - dicyclomine
KW - dosage
KW - drug interactions
KW - efficacy
KW - eluxadoline
KW - fiber
KW - hyoscyamine
KW - imipramine
KW - irritable bowel syndrome
KW - linaclotide
KW - loperamide
KW - lubiprostone
KW - nortriptyline
KW - ondansetron
KW - peppermint oil
KW - plecanatide
KW - polyethylene glycol
KW - probiotics
KW - psyllium
KW - rifaximin
KW - safety
KW - tenapanor
KW - tricyclic antidepressants
SP - 17
EP - 24
JF - The Medical letter on drugs and therapeutics
JO - Med Lett Drugs Ther
VL - 67
IS - 1721
SN - 1523-2859
UR - https://www.unboundmedicine.com/prime/citation/39912839/Drugs_for_irritable_bowel_syndrome.
DB - PRIME
DP - Unbound Medicine
ER -
